Submitted by Anonymous (not verified) on 23 April 2026 - 13:18
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 21, Status: Authorised